Cart
sales@molnova.com
(2E,4E)-2,4-Decadienoic acid
CAS No. 30361-33-2
(2E,4E)-2,4-Decadienoic acid( ——— )
Catalog No. M38608 CAS No. 30361-33-2
(2E,4E)-Decadienoic acid is an anti-oomycete aliphatic compound that can be found in Coculture of Bacillus subtilis and Trichoderma asperellum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(2E,4E)-2,4-Decadienoic acid
-
NoteResearch use only, not for human use.
-
Brief Description(2E,4E)-Decadienoic acid is an anti-oomycete aliphatic compound that can be found in Coculture of Bacillus subtilis and Trichoderma asperellum.
-
Description(2E,4E)-Decadienoic acid is an anti-oomycete aliphatic compound that can be found in Coculture of Bacillus subtilis and Trichoderma asperellum.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number30361-33-2
-
Formula Weight168.2328
-
Molecular FormulaC10H16O2
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang XF, et, al. 2 E,4 E-Decadienoic Acid, a Novel Anti-Oomycete Agent from Coculture of Bacillus subtilis and Trichoderma asperellum. Microbiol Spectr. 2022 Aug 31;10(4):e0154222.?
molnova catalog
related products
-
Pomolic acid 28-O-be...
Pomolic acid 28-O-beta-D-glucopyranosyl ester is a natural product.
-
Crassicauline A
Crassicauline A and Yunaconitine possesses feeding deterrent activity against T. castaneum adults, with EC(5) values of 1134.5 and 653.4 ppm, respectively.
-
111-Undecanedicarbox...
Undecanedicarboxylic acid is an unusual odd-numbered dicarboxylic acid that appears in the urines of children with neonatal adrenoleukodystrophy and Zellweger syndrome as an additional marker of these peroxisomal disorders.
